Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy | Zendy

Ayman AlHendy | Zendy; Andrea S. Lukes | Zendy; Alfred N. Poindexter | Zendy; Roberta Venturella | Zendy; Claudio Villarroel | Zendy; Hilary Critchley | Zendy; Yulan Li | Zendy; Laura McKain | Zendy; Juan Camilo Arjona Ferreira | Zendy; Andria Langenberg | Zendy; Rachel B. Wagman | Zendy; Elizabeth A. Stewart | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Author(s) -

Ayman AlHendy,

Andrea S. Lukes,

Alfred N. Poindexter,

Roberta Venturella,

Claudio Villarroel,

Hilary Critchley,

Yulan Li,

Laura McKain,

Juan Camilo Arjona Ferreira,

Andria Langenberg,

Rachel B. Wagman,

Elizabeth A. Stewart

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2008283

Subject(s) - uterine fibroids , medicine , ulipristal acetate , gynecology , menstrual bleeding , menstrual cycle , hormone antagonist , antagonist , uterine bleeding , hormone , obstetrics , research methodology , receptor , family planning , population , environmental health

Uterine fibroids are a common cause of heavy menstrual bleeding and pain. Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone-receptor antagonist), estradiol, and norethindrone acetate, administered once daily, may have efficacy in women with uterine fibroids and heavy bleeding while avoiding hypoestrogenic effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research